Bishop the last 2 announcements with RX are not great news
Bishop the last 2 announcements with RX are not great news candidly. In reality in q2 we did less then we did in q1. However RX is a complete non-event as its showing. The good thing is we practically do nothing and collect 100knet (14% of 700k) so it pays some of the bills.
Here are my thoughts: when we announce cash flow positive which I believe in late August many more eyes will be on us. Remember Bishop there re probably 40m to 50m shares that already have been bought by the "core" the last 15 months. So it will not take much to move.
I believe it will take 2 quarters for the market to discover this gem it needs to see q3 and q4. If we do 11m in q3 and achieve .015 cents and then 13m to 14m on .025 cents it is going to get noticed. We don't need massive volume to take us there as all the notes are gone per the pr's announced.
This action is not surprising as its not EXCITING at all. I am more interested in PIMD, Compounding, and rapimeds the big 3 will move this needle. we are on ly 2 weeks away from seeing compounding #s which imho will exceed 3m in revs that we net approx 20% thats 600k for the month!!! Thats very exciting as I have to believe when we collect that we will see cash flow positive pretty soon. I expect POSITIVE EPS IN Q3 .015 CENTS THAT IS A BIG DEAL!!~!!!!!!!!!!!!
ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
MIT45's Firm Stance on Kratom Safety MIT45, a leading name in the kratom market, stands firmly against the irresponsible and hazardous practice of producing synthetic 7-hydroxymitragynine (7-OH). This commitment to consumer protection is especially important as products claiming to contain kratom often do not meet safety standards and could threaten public health. By...
Continue Reading
Canso Credit Income Fund's Special Distributions Explained Lysander Funds Limited is excited to share important updates regarding the Canso Credit Income Fund (TSX: PBY). This announcement pertains to the special distributions being issued for various classes of units within the Fund for the tax year ending 2024. Understanding these distributions is vital for both...
Continue Reading
Blue Cross and Blue Shield of Texas Awards Community Grants Blue Cross and Blue Shield of Texas (BCBSTX) has announced an impressive investment of $2 million in community-based grants. This funding will go to 84 organizations across the state, all focused on enhancing accessibility to health services and tackling social determinants that significantly impact the...
Continue Reading
Welcoming Dr. Soroush Baghdadi to Luskin Orthopaedic Institute The Luskin Orthopaedic Institute for Children takes great pride in announcing the addition of Dr. Soroush Baghdadi to its distinguished team of pediatric orthopaedic specialists. With an impressive background enriched by global experience and a passion for pediatric care, Dr. Baghdadi brings a promising vision...
Continue Reading
Fractyl Health to Discuss Upcoming Financial Insights In Burlington, Massachusetts, Fractyl Health, Inc. (Nasdaq: GUTS) is preparing to unveil its financial results for the third quarter of 2025 along with business updates. This event is scheduled for a Wednesday at 4:30 PM ET, where key insights into the company’s progress will be shared. Accessing the Live Event...
Continue Reading